Hypoxic regions exist in human prostate carcinoma

Urology

Volumn 53, Issue 1, 1999, Pages 11-18

  Movsas, Benjamin ^a   Chapman, J Donald ^a   Horwitz, Eric M ^a   Pinover, Wayne H ^a   Greenberg, Richard E ^a   Hanlon, Alexandra L ^a   Iyer, Renuka ^a   Hanks, Gerald E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOXIA; MALE; MALE GENITAL TRACT CANCER; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; TISSUE OXYGENATION;

ADULT; AGED; CELL HYPOXIA; HUMANS; MALE; MICROELECTRODES; MIDDLE AGED; OXYGEN; PROSTATIC NEOPLASMS;

EID: 0032957390     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00500-7     Document Type: Article

References (26)

1. Movsas B., Hanlon A.L., Hanks G.E. Analyzing predictive models following definitive radiotherapy for prostate cancer. Cancer. 80:1997;1093-1102.
2. Gatenby R.A., Kessler H.B., Rosenblum J.S., et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys. 14:1988;831-838.
3. Nordsmark M., Overgaard M., Overgaard J. Oxygenation status predicts radiation response in advanced squamous cell carcinoma of head and neck. Radiother Oncol. 41:1996;31-39.
4. Brizel D.M.N., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 38:1997;285-289.
5. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol. 26:1993;45-50.
6. Höckel M., Schlenger K., Aral B., et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56:1996;4509-4515.
7. Groshar D., McEwan A.J., Parliament M.B., et al. Imaging tumor hypoxia and tumor perfusion. J Nucl Med. 34:1993;885-888.
8. Urtasun R.C., McEwan A.J., Parliament M.B., et al. Measurement of hypoxia in human tumors by SPECT imaging of iodoazomycin arabinoside. Br J Cancer. 74:1996;209-212.
9. 18F]fluoromisonidazole a pretherapy study of 37 patients . Int J Radiat Oncol Biol Phys. 36:1996;417-428.
10. Yeh K.A., Biade S., Lanciano R.M., et al. Polarographic needle electrode measurements of oxygen in rat prostate carcinomas accuracy and reproducibility . Int J Radiat Oncol Biol Phys. 33:1995;111-118.
11. Teicher B.A., Schwartz G.N., Dupuis N.P., et al. Oxygenation of human tumor xenografts in nude mice by a perfluorochemical emulsion and carbogen breathing. Artif Cells Blood Substit Immobil Biotechnol. 22:1995;1369-1375.
12. 2 tension measurements . Cancer Res. 51:1991;3316-3322.
13. 2 distribution of human brain tumors determined by fine needle polarography. Adv Exp Med Biol. 345:1994;465-470.
14. Chapman J.D., Engelhardt E.L., Stobbe C.C., et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol. 46:1998;229-237.
15. Pilepich M.V., Krall J.M., Sause W.T., et al. Correlation of radiotherapeutic parameters and treatment-related morbidity in carcinoma of the prostate - analysis of RTOG study 75-06. Int J Radiat Oncol Biol Phys. 13:1987;351-358.
16. Paulson D.F. Carcinoma of the prostate the therapeutic dilemma . Annu Rev Med. 35:1984;341-372.
17. Hanks G.E., Krall J.M., Hanlon A.L., et al. Patterns of care and RTOG studies in prostate cancer long-term survival, hazard rate observations, and possibilities of cure . Int J Radiat Oncol Biol Phys. 28:1993;39-45.
18. Pilepich M.V., Krall J.M., Al-Sarraf M., et al. Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma - a randomized comparative trial of the Radiation Therapy Oncology Group. Urology. 45:1995;616-623.
19. Russell K.J., Caplan R.J., Laramore G.E., et al. Photon versus fast neutron external beam radiotherapy in the treatment of locally advanced prostate cancer results of a randomized prospective trial . Int J Radiat Oncol Biol Phys. 28:1994;47-54.
20. Hanks GE, Hanlon AL, Lee WR, et al: Conformal treatment of prostate cancer: effects on cancer control and morbidity. Presented at the Fifth International Meeting on Progress in Radio-Oncology, May 1995, Salzburg, Austria.
21. Stromberg J.S., Martinez A.A., Horwitz E.M., et al. Conformal high dose rate Ir-192 boost brachytherapy in locally advanced prostate cancer superior prostate specific antigen response compared to external beam treatment . Cancer J Sci Am. 3:1997;346-352.
22. Hanks G.E., Hanlon A.L., Schultheiss T.E., et al. Dose escalation with 3D conformal treatment five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
23. Pinover WH, Hanlon AL, Horwitz EM, et al: Defining the appropriate dose for prostate cancer patients with PSA < 10 ng/ml. Accepted as oral presentation. ASTRO Proceedings, 1998, Phoenix, Arizona.
24. Brown J.M., Giaccia A.J. Tumour hypoxia the picture has changed in the 1990's . Int J Radiat Biol. 65:1994;95-102.
25. Overgaard J., Horsman M.R. Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol. 6:1996;10-21.
26. Moulder J.E., Rockwell S. Tumor hypoxia its impact on cancer therapy . Cancer Metastasis Rev. 5:1987;313-341.